Impact of Photobiomodulation on Objective, Physiological Measures of Brain Function in Individuals With Post-Concussion Syndrome
Post-Concussive Syndrome, Chronic, Post-Concussion Syndrome, Mild Traumatic Brain Injury
About this trial
This is an interventional treatment trial for Post-Concussive Syndrome, Chronic
Eligibility Criteria
Inclusion Criteria:
- Male or female, at least 19 years of age or older
- Diagnosis of persistent post-concussional syndrome after ≥3 months of traumatic brain injury, based on the ICD-10 criteria. This diagnosis should be given to the patient from a clinical practitioner. ICD-10 clinical criteria require a history of TBI and the presence of three or more of the following eight symptoms: 1) headache, 2) dizziness, 3) fatigue, 4) irritability, 5) insomnia, 6) concentration or 7) memory difficulty, and 8) intolerance of stress, emotion, or alcohol.
- Current pharmacologic management can remain stable throughout the protocol.
- Fluent in English
- Able to understand the informed consent form, study procedures and willing to participate in study.
Exclusion Criteria:
- Malignant skin carcinoma within the treatment area (neck and cranium)
- Intake of photosensitizing medication.
- Prior history of PBMT therapy
- Current diagnosis of severe anxiety (or score of ≥15 on the GAD-7), severe depression (or score of ≥20 on the PHQ-9), schizophrenia or bipolar disorder
- History of other major neurological disorder (brain cancer, dementia, multiple sclerosis, stroke)
- Diagnosed epilepsy or history of seizures not effectively controlled by medications
- Exposed to an investigational drug or device 30 days prior to starting the study, or concurrent use of an investigational drug or device while enrolled in the study
- Pregnant, suspected to be pregnant or planning to become pregnant during the study
- Contraindicated for the NeuroCatch® Platform 2, including:
9.1. Requires the use of hearing aids or a cochlear implant 9.2. Diagnosed with tinnitus that is currently active 9.3. Has temporary damage to hearing (e.g. punctured ear drum) 9.4. Unable to detect a 740Hz tone played at 85dB in both ears. 9.5. Implanted pacemaker or implanted electrical stimulators 9.6. Metal or plastic implants in the skull, excluding dental/facial implants 9.7. Unhealthy scalp (apparent open wounds and/or bruised or weakened skin) 9.8. Previous exposure to the NeuroCatch® Platform 2 audio sequences in the last 3 months
Sites / Locations
- Center for Neurology StudiesRecruiting
- Meditech Rehabilitation CentreRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Active PBMT
Sham PBMT
Participants will receive 50minutes of PBMT, three times a week, for 8 weeks.
Participants will receive 50minutes of Sham PBMT, three times a week, for 8 weeks. The Sham device will appear to function like the treatment device without providing any power intensity (0% power). At 0% power, no light is emitted from the LEDs.